Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
22.59
+0.48 (2.17%)
May 28, 2026, 3:36 PM EDT - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $2.56 billion as of May 28, 2026. Its market cap has increased by 270.30% in one year.
Market Cap
2.56B
Enterprise Value
1.97B
1-Year Change
270.30%
Ranking
Category
Stock Price
$22.59
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.56B, an increase of 2,196.71%. That is a compound annual growth rate of 74.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 2.50B | 5.66% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 2.73B |
| Alumis | 2.70B |
| Disc Medicine | 2.69B |
| Tarsus Pharmaceuticals | 2.59B |
| IDEAYA Biosciences | 2.55B |
| Mineralys Therapeutics | 2.53B |
| Celldex Therapeutics | 2.50B |
| Enliven Therapeutics | 2.49B |